骨骼生长刺激器市场－全球产业规模、份额、趋势、机会和预测（按类型、应用、最终用户、地区和竞争细分，2020-2030 年）

2024 年全球骨骼生长刺激器市值为 12.4 亿美元，预计到 2030 年将达到 16.8 亿美元，预测期内的复合年增长率为 5.19%。全球骨骼生长刺激器市场正在经历显着增长，这得益于老年人口的增长以及全球意外伤害和骨骼疾病发病率的上升。此外，关节炎、糖尿病类疾病以及肥胖、血管疾病、肾臟疾病等其他疾病的盛行率上升，以及对微创和非侵入性外科治疗的需求增加，是推动市场多年来成长的主要因素。此外，人们对骨骼生长刺激器及其在治疗骨折和骨科疾病方面提供的程序益处的认识不断提高，进一步推动了预测期内的市场成长。

关键市场驱动因素

骨骼疾病和骨折发生率上升

主要市场挑战

骨骼生长刺激器成本高昂

主要市场趋势

穿戴式与智慧科技的融合

目录

第 1 章：产品概述

第二章：研究方法

第三章：执行摘要

第四章：顾客之声

第五章：全球骨骼生长刺激器市场展望

• 市场规模和预测
  • 按价值
• 市场占有率和预测
  • 依类型（外部骨骼生长刺激器、超音波骨骼生长刺激器、植入式骨骼生长刺激器）
  • 按应用（脊椎融合手术、骨折延迟癒合和不癒合、口腔颚面手术、其他）
  • 按最终使用者（医院和门诊手术中心、家庭护理机构、学术和研究机构）
  • 按地区
  • 按公司分类（2024）
• 市场地图
  • 按类型
  • 按应用
  • 按最终用户
  • 按地区

第六章：北美骨生长刺激器市场展望

• 市场规模和预测
• 市场占有率和预测
• 北美：国家分析
  • 美国
  • 加拿大
  • 墨西哥

第七章：欧洲骨骼生长刺激器市场展望

• 市场规模和预测
• 市场占有率和预测
• 欧洲：国家分析
  • 法国
  • 德国
  • 英国
  • 义大利
  • 西班牙

第八章：亚太骨骼生长刺激器市场展望

• 市场规模和预测
• 市场占有率和预测
• 亚太地区：国家分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

第九章：南美骨骼生长刺激器市场展望

• 市场规模和预测
• 市场占有率和预测
• 南美洲：国家分析
  • 巴西
  • 阿根廷
  • 哥伦比亚

第 10 章：中东和非洲骨骼生长刺激器市场展望

• 市场规模和预测
• 市场占有率和预测
• MEA：国家分析
  • 南非
  • 沙乌地阿拉伯
  • 阿联酋

第 11 章：市场动态

• 驱动程式
• 挑战

第 12 章：市场趋势与发展

• 最新进展
• 产品发布
• 併购

第 13 章：全球骨骼生长刺激器市场：SWOT 分析

第 14 章：波特五力分析

• 产业竞争
• 新进入者的潜力
• 供应商的力量
• 顾客的力量
• 替代产品的威胁

第 15 章：竞争格局

• Colfax Corporation
• Arthrex
• Essex Woodlands Healthcare Partners
• Isto Biologics
• Johnson and Johnson
• Medtronic Plc
• Orthofix Medical Inc.
• Stryker Corporation
• Terumo Corporation
• Zimmer Biomet Holdings

第 16 章：策略建议

第17章调查会社について・免责事项

Global Bone Growth Stimulator Market was valued at USD 1.24 billion in 2024 and is expected to reach USD 1.68 billion by 2030 with a CAGR of 5.19% during the forecast period. The global market for Bone Growth Stimulator is experiencing significant growth, driven by the growing geriatric population along with the increasing incidences of accidental injuries along with bone disorders across the globe. Additionally, the rising prevalence of arthritis, diabetes-like diseases, and other medical conditions like obesity, vascular diseases, renal disorder and increasing demand for minimally invasive and non-invasive surgical treatments are the major factors driving the growth of the market over the years. Additionally, growing awareness about bone growth stimulators and procedural benefits provided by bone growth stimulators for the treatment of bone fracture and orthopedic diseases is further boosting the market growth during the forecast period.

Key Market Drivers

Rising Incidence of Bone Disorders and Fractures

A key driver of the bone growth stimulator market is the global rise in the incidence of bone-related conditions, including fractures, osteoporosis, and spinal disorders. According to the World Health Organization (WHO), osteoporosis is estimated to affect more than 200 million people globally, with millions suffering fractures because of weakened bones. In the U.S. alone, the Centers for Disease Control and Prevention (CDC) reports over 8.9 million osteoporotic fractures annually. The aging population is a major contributor to this increase, with the United Nations projecting that the global population aged 65 and above will more than double from 761 million in 2021 to 1.6 billion by 2050. As bone healing tends to be slower in elderly individuals, the demand for non-invasive, supportive treatments like bone growth stimulators is growing. These devices, which use ultrasound or electrical pulses to stimulate natural bone regeneration, are increasingly adopted post-surgery and in complex fractures. Additionally, sports-related injuries in younger demographics have also contributed to the growing demand, with bone stimulators offering an effective adjunct therapy to speed up healing.

Key Market Challenges

High Cost of Bone Growth Stimulator Devices

Despite their clinical benefits, bone growth stimulators remain relatively expensive and are often not accessible to a wide segment of the population, particularly in low- and middle-income countries. The upfront cost of a single device can run into thousands of dollars, posing a financial barrier for patients without insurance or adequate healthcare coverage. Even in developed nations, many private insurers and national health services impose stringent guidelines for reimbursement, limiting patient access unless certain clinical criteria are met. According to Medicare guidelines in the U.S., coverage is generally limited to specific non-union fractures that haven't shown signs of healing after 90 days, excluding broader use cases such as preventive post-operative care. Additionally, the recurring costs associated with consumables, servicing, and clinician training further burden hospitals and healthcare providers. These cost-related barriers hinder widespread adoption, particularly in emerging markets where healthcare budgets are limited. Without broader reimbursement frameworks or subsidy programs, the penetration of these devices remains constrained despite clinical efficacy.

Key Market Trends

Integration of Wearable and Smart Technologies

A growing trend in the bone growth stimulator market is the incorporation of wearable and smart technology features into traditional stimulation devices. With increasing digitization in healthcare, next-generation stimulators are being developed with features such as Bluetooth connectivity, real-time treatment tracking, mobile app integration, and data analytics. These innovations help clinicians monitor patient compliance, treatment effectiveness, and adjust protocols remotely. In line with global efforts to promote home-based healthcare and reduce hospital remissions, such advancements improve both the convenience and outcomes of bone healing treatments. Governments and health authorities, including the European Commission's eHealth Action Plan, are increasingly supporting digital health innovations that reduce the burden on centralized health systems. By integrating sensors and AI-driven insights, companies are creating personalized therapy plans that align with the broader movement toward precision medicine. As wearable technologies become more affordable and user-friendly, their role in orthopedic rehabilitation is expected to expand significantly.

Key Market Players

• Colfax Corporation
• Arthrex
• Essex Woodlands Healthcare Partners
• Isto Biologics
• Johnson and Johnson
• Medtronic Plc
• Orthofix Medical Inc.
• Stryker Corporation
• Terumo Corporation
• Zimmer Biomet Holdings

Report Scope:

In this report, the Global Bone Growth Stimulator Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Bone Growth Stimulator Market, By Type:

• External Bone Growth Stimulators
• Ultrasonic Bone Growth Stimulators
• Implanted Bone Growth Stimulators

Bone Growth Stimulator Market, By Application:

• Spinal Fusion Surgeries
• Delayed Union and Non-union Bone Fractures
• Oral and Maxillofacial Surgeries
• Others

Bone Growth Stimulator Market, By End User:

• Hospital and Ambulatory Surgery Centres
• Home Care Settings
• Academic and Research Institutes

Bone Growth Stimulator Market, By Region:

• North America
  • United States
  • Mexico
  • Canada
• Europe
  • France
  • Germany
  • United Kingdom
  • Italy
  • Spain
• Asia-Pacific
  • China
  • India
  • South Korea
  • Japan
  • Australia
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Bone Growth Stimulator Market.

Available Customizations:

Global Bone Growth Stimulator Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Bone Growth Stimulator Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Type (External Bone Growth Stimulators, Ultrasonic Bone Growth Stimulators, Implanted Bone Growth Stimulators)
  • 5.2.2. By Application (Spinal Fusion Surgeries, Delayed Union, and Non-union Bone Fractures, Oral and Maxillofacial Surgeries, Others)
  • 5.2.3. By End User (Hospital and Ambulatory Surgery Centres, Home Care Settings, Academic and Research Institutes)
  • 5.2.4. By Region
  • 5.2.5. By Company (2024)
• 5.3. Market Map
  • 5.3.1. By Type
  • 5.3.2. By Application
  • 5.3.3. By End User
  • 5.3.4. By Region

6. North America Bone Growth Stimulator Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Type (External Bone Growth Stimulators, Ultrasonic Bone Growth Stimulators, Implanted Bone Growth Stimulators)
  • 6.2.2. By Application (Spinal Fusion Surgeries, Delayed Union, and Non-union Bone Fractures, Oral and Maxillofacial Surgeries, Others)
  • 6.2.3. By End User (Hospital and Ambulatory Surgery Centres, Home Care Settings, Academic and Research Institutes)
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Bone Growth Stimulator Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Type
      • 6.3.1.2.2. By Application
      • 6.3.1.2.3. By End User
  • 6.3.2. Canada Bone Growth Stimulator Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Type
      • 6.3.2.2.2. By Application
      • 6.3.2.2.3. By End User
  • 6.3.3. Mexico Bone Growth Stimulator Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Type
      • 6.3.3.2.2. By Application
      • 6.3.3.2.3. By End User

7. Europe Bone Growth Stimulator Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Type (External Bone Growth Stimulators, Ultrasonic Bone Growth Stimulators, Implanted Bone Growth Stimulators)
  • 7.2.2. By Application (Spinal Fusion Surgeries, Delayed Union, and Non-union Bone Fractures, Oral and Maxillofacial Surgeries, Others)
  • 7.2.3. By End User (Hospital and Ambulatory Surgery Centres, Home Care Settings, Academic and Research Institutes)
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. France Bone Growth Stimulator Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Type
      • 7.3.1.2.2. By Application
      • 7.3.1.2.3. By End User
  • 7.3.2. Germany Bone Growth Stimulator Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Type
      • 7.3.2.2.2. By Application
      • 7.3.2.2.3. By End User
  • 7.3.3. United Kingdom Bone Growth Stimulator Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Type
      • 7.3.3.2.2. By Application
      • 7.3.3.2.3. By End User
  • 7.3.4. Italy Bone Growth Stimulator Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Type
      • 7.3.4.2.2. By Application
      • 7.3.4.2.3. By End User
  • 7.3.5. Spain Bone Growth Stimulator Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Type
      • 7.3.5.2.2. By Application
      • 7.3.5.2.3. By End User

8. Asia-Pacific Bone Growth Stimulator Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Type (External Bone Growth Stimulators, Ultrasonic Bone Growth Stimulators, Implanted Bone Growth Stimulators)
  • 8.2.2. By Application (Spinal Fusion Surgeries, Delayed Union, and Non-union Bone Fractures, Oral and Maxillofacial Surgeries, Others)
  • 8.2.3. By End User (Hospital and Ambulatory Surgery Centres, Home Care Settings, Academic and Research Institutes)
  • 8.2.4. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Bone Growth Stimulator Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Type
      • 8.3.1.2.2. By Application
      • 8.3.1.2.3. By End User
  • 8.3.2. India Bone Growth Stimulator Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Type
      • 8.3.2.2.2. By Application
      • 8.3.2.2.3. By End User
  • 8.3.3. Japan Bone Growth Stimulator Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Type
      • 8.3.3.2.2. By Application
      • 8.3.3.2.3. By End User
  • 8.3.4. South Korea Bone Growth Stimulator Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Type
      • 8.3.4.2.2. By Application
      • 8.3.4.2.3. By End User
  • 8.3.5. Australia Bone Growth Stimulator Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Type
      • 8.3.5.2.2. By Application
      • 8.3.5.2.3. By End User

9. South America Bone Growth Stimulator Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Type (External Bone Growth Stimulators, Ultrasonic Bone Growth Stimulators, Implanted Bone Growth Stimulators)
  • 9.2.2. By Application (Spinal Fusion Surgeries, Delayed Union, and Non-union Bone Fractures, Oral and Maxillofacial Surgeries, Others)
  • 9.2.3. By End User (Hospital and Ambulatory Surgery Centres, Home Care Settings, Academic and Research Institutes)
  • 9.2.4. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Bone Growth Stimulator Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Type
      • 9.3.1.2.2. By Application
      • 9.3.1.2.3. By End User
  • 9.3.2. Argentina Bone Growth Stimulator Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Type
      • 9.3.2.2.2. By Application
      • 9.3.2.2.3. By End User
  • 9.3.3. Colombia Bone Growth Stimulator Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Type
      • 9.3.3.2.2. By Application
      • 9.3.3.2.3. By End User

10. Middle East and Africa Bone Growth Stimulator Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Type (External Bone Growth Stimulators, Ultrasonic Bone Growth Stimulators, Implanted Bone Growth Stimulators)
  • 10.2.2. By Application (Spinal Fusion Surgeries, Delayed Union, and Non-union Bone Fractures, Oral and Maxillofacial Surgeries, Others)
  • 10.2.3. By End User (Hospital and Ambulatory Surgery Centres, Home Care Settings, Academic and Research Institutes)
  • 10.2.4. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Bone Growth Stimulator Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Type
      • 10.3.1.2.2. By Application
      • 10.3.1.2.3. By End User
  • 10.3.2. Saudi Arabia Bone Growth Stimulator Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Type
      • 10.3.2.2.2. By Application
      • 10.3.2.2.3. By End User
  • 10.3.3. UAE Bone Growth Stimulator Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Type
      • 10.3.3.2.2. By Application
      • 10.3.3.2.3. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Advancements
• 12.2. Product Launches
• 12.3. Mergers & Acquisitions

13. Global Bone Growth Stimulators Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Product

15. Competitive Landscape

• 15.1. Colfax Corporation
  • 15.1.1. Business Overview
  • 15.1.2. Company Snapshot
  • 15.1.3. Products & Services
  • 15.1.4. Financials (As Reported)
  • 15.1.5. Recent Developments
  • 15.1.6. Key Personnel Details
  • 15.1.7. SWOT Analysis
• 15.2. Arthrex
• 15.3. Essex Woodlands Healthcare Partners
• 15.4. Isto Biologics
• 15.5. Johnson and Johnson
• 15.6. Medtronic Plc
• 15.7. Orthofix Medical Inc.
• 15.8. Stryker Corporation
• 15.9. Terumo Corporation
• 15.10. Zimmer Biomet Holdings

16. Strategic Recommendations

17. About Us & Disclaimer